SPARSH BIOTECH is rapidly establishing itself as a significant player in the pharmaceutical sector, particularly recognized for its advanced process of producing Amoxycillin and Augmentin. The company boasts state-of-the-art facilities and a dedicated team guaranteeing excellent antibiotics serving patients internationally.